Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bavarian Nordic is a specialized biopharmaceutical company dedicated to the development, manufacturing, and distribution of life-saving vaccines and immunotherapies. The company focuses on the prevention and treatment of serious infectious diseases and certain cancers, thereby contributing to global health.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bavarian Nordic is scheduled to report its next quarterly earnings on 11/13/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Bavarian Nordic last reported quarterly earnings on 8/21/2026 (Q2 2026). Earnings per share (EPS) came in at 9.40 DKK.
Across its last 4 earnings reports, Bavarian Nordic stock moved by ±4.5% on average the following day. The largest reaction was +9.1% on 08/21/2026; 1 of 4 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.